Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors-Reference-Cited by-同舟云学术

Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors

Published:2016-04-15 Issue:8 Volume:59 Page:3886-3905
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Daydé-Cazals Bénédicte¹,Fauvel Bénédicte¹,Singer Mathilde¹,Feneyrolles Clémence¹,Bestgen Benoit¹,Gassiot Fanny¹,Spenlinhauer Aurélia¹,Warnault Pierre¹,Van Hijfte Nathalie¹,Borjini Nozha¹,Chevé Gwénaël¹,Yasri Abdelaziz¹

Affiliation:

1. OriBase Pharma, Cap Gamma, Parc Euromédecine, 1682 rue de la Valsière, CS 17383, Montpellier 34189 CEDEX 4, France

Funder

OriBase Pharma

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00087

Reference23 articles.

1. Targeting cancer with small molecule kinase inhibitors

2. Recently targeted kinases and their inhibitors—the path to clinical trials

3. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

4. Selection and adaptation during metastatic cancer progression

5. Targeting Multiple Kinase Pathways: A Change In Paradigm: Fig. 1.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. I2/CAN as an efficient reagent for the direct oxidation of tertiary Csp3-H to Csp3-OH: Synthesis of bis(N-methyl-7-azaindol-3-yl) (phenyl) methanol from 3,3′-(phenyl methylene)-bis(N-methyl-7-azaindole);Tetrahedron Letters;2024-09

2. Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis;RSC Advances;2024

3. I2/Can as an Efficient Reagent for the Direct Oxidation of Tertiary Csp3-H to Csp3-Oh: Synthesis of Bis(N-Methyl-7-Azaindol-3-Yl) (Phenyl) Methanol from 3,3'-(Phenyl Methylene)-Bis(N-Methyl-7-Azaindole);2024

4. An insight into the structure–activity relationship studies of anticancer medicinal attributes of 7-azaindole derivatives: a review;Future Medicinal Chemistry;2023-12

5. Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure‐Activity Relationship;Chemistry & Biodiversity;2023-09